Genetic similarity of circulating and small intestinal virus at the end stage of acute pathogenic simian-human immunodeficiency virus infection. Matsuyama-Murata M, Inaba K, Horiuchi R, Fukazawa Y, Ibuki K, Hayami M, Miura T. Front Microbiol. 2013 4: 204.

 

Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus. Himeno A, Akagi T, Uto T, Wang X, Baba M, Ibuki K, Matsuyama M, Horiike M, Igarashi T, Miura T, Akashi M. Vaccine. 2010 Jul 19; 28(32): 5377-85.

 

Small intestine CD4+ cell reduction and enteropathy in simian/human immunodeficiency virus KS661-infected rhesus macaques in the presence of low viral load. Inaba K, Fukazawa Y, Matsuda K, Himeno A, Matsuyama M, Ibuki K, Miura Y, Koyanagi Y, Nakajima A, Blumberg RS, Takahashi H, Hayami M, Igarashi T, Miura T. J Gen Virol. 2010 Mar; 91 :773-81.

 

Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy. Suzuki T, Yamamoto N, Nonaka M, Hashimoto Y, Matsuda G, Takeshima SN, Matsuyama M, Igarashi T, Miura T, Tanaka R, Kato S, Aida Y. Biochem Biophys Res Commun. 2009 Mar 20; 380 (4): 838-43.

 

In vivo analysis of a new R5 tropic SHIV generated from the highly pathogenic SHIV-KS661, a derivative of SHIV-89.6. Matsuda K, Inaba K, Fukazawa Y, Matsuyama M, Ibuki K, Horiike M, Saito N, Hayami M, Igarashi T, Miura T. Virology 2010 399,134–143

 

Small Intestine CD4+ T Cells Are Profoundly Depleted during Acute Simian-Human Immunodeficiency Virus Infection, Regardless of Viral Pathogenicity. Fukazawa Y, Miyake A, Ibuki K, Inaba K, Saito N, Motohara M, Horiuchi R, Himeno A, Matsuda K, Matsuyama M, Takahashi H, Hayami M, Igarashi T, Miura T. Journal of virology, 2008 June, Vol. 82, No. 12 p. 6039–6044

 

Whole genome sequence data of an infectious molecular clone of the SIVagm TYO-1 strain. Miura T, Matsuyama M, Ogatsu F, Hayami M. AIDS Res Hum Retroviruses. 2006 Nov; 22(11): 1183-5.